30+ years of experience in Russia
14 partners
100+ lawyers
160+ offices in 80 countries around the world in the form of a powerful partner network of global support Dentons
20+ Russian and international ratings confirming the team's professionalism and reputation in Russia

Nextons is one of the largest teams of legal professionals in Russia and was formerly known as Dentons' Russian practice.

What Our Clients Say
Recognition
News
and Events
27 January 2026
Vladislav Shiyanov has joined Nextons as head of Life Sciences practice
Vladislav is a strategic legal advisor with over 15 years of international experience in the pharmaceutical and healthcare sectors, covering 30+ jurisdictions, including Russia, the EAEU countries, Central and Eastern Europe, UK, and Ireland. Previously, he was responsible for providing legal support to companies such as AbbVie, Allergan Aesthetics, AstraZeneca, and Egis Pharmaceuticals.
30 December 2025
Season’s Greetings from the Nextons Team!
May the coming year bring you happiness and joyful moments, love and kindness, prosperity and good fortune, inspiration and new achievements!
31 October 2025
Nextons represented GloraX in its IPO on the Moscow Stock Exchange
Nextons represented PJSC GLORAX (GloraX), one of the leading Real Estate developers, operating in multiple regions across Russia, in its circa RUB 2.1 billion initial public offering (IPO) and listing of its shares on the Moscow Stock Exchange (MOEX).
1 October 2025
Nextons Strengthens Corporate/M&A and Capital Markets Practices
Nextons strengthens Corporate/M&A and Capital Markets practices. Bulat Zhambalnimbuev, partner, Denis Borisov and Dina Iskanderova, counsels, Kseniia Mikhailova, senior associate, and Erik Kazaryan, Kirill Evstifeev, and Kirill Khrapov, associates, have joined the team.
27 June 2025
Gains from losses and double tax: three illustrative court cases
Judges have ruled on three illustrative cases. In all of them, companies had to pay taxes at a time when they were not expecting it at all and when their actions seemed to be legal, as Oksana Goncharova detailed in the Tax Review for the first quarter of 2025.